Teglicar structure
|
Common Name | Teglicar | ||
|---|---|---|---|---|
| CAS Number | 250694-07-6 | Molecular Weight | 399.61100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H45N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TeglicarTeglicar is a selective and reversible inhibitor of liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). Teglicar reduces ketogenesis and glucose production, decreases gluconeogenesis and improves glucose homeostasis. Teglicar has a potential antihyperglycemic propert[1]. |
| Name | Teglicar |
|---|---|
| Synonym | More Synonyms |
| Description | Teglicar is a selective and reversible inhibitor of liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). Teglicar reduces ketogenesis and glucose production, decreases gluconeogenesis and improves glucose homeostasis. Teglicar has a potential antihyperglycemic propert[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: L-CPT1[1] |
| References |
| Molecular Formula | C22H45N3O3 |
|---|---|
| Molecular Weight | 399.61100 |
| Exact Mass | 399.34600 |
| PSA | 81.26000 |
| LogP | 3.98330 |
| (R)-4-Trimethylammonio-3-[(tetradecylcarbamoyl)amino]butyrate |
| ST 1326 |
| 3-(TETRADECYLCARBAMOYLAMINO)-4-TRIMETHYLAMMONIO-BUTANOATE |
| 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[[(tetradecylamino)carbonyl]amino]-,inner salt,(2R) |
| R-4-trimethylammonium-3-(tetradecylcarbamoyl)-aminobutyrate |
| 3-(tetradecylcarbamoylamino)-4-(trimethylazaniumyl)butanoate |
| 4-trimethylammonium-(R)-3-(tetradecylcarbamoyl)-amino butyrate |